Position in NTRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,047,147
+$4,799,138 QoQ
Shares Held
25,237
+260.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Bridgewater Associates, LP holds $91,176,029 across 18 Diagnostics & Research names. NTRA ranks #8 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
41,135 | $19,752,615 | |
| 2 | SHC |
Sotera Health Co
|
695,392 | $9,971,921 | |
| 3 | A |
Agilent Technologies, Inc.
|
73,689 | $8,399,072 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
47,119 | $8,035,674 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
14,487 | $7,120,795 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
5,138 | $6,480,045 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
10,314 | $5,795,333 | |
| 8 | NTRA |
Natera, Inc.
This page
|
25,237 | $5,047,147 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,047,147 | 25,237 | Shares | Sole | 2026-05-15 | |
| 2022-06-30 | $248,009 | 6,998 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $218,777 | 5,378 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||